Tarsus Pharmaceuticals grants chief commercial officer 10,587 stock options, 6,678 restricted stock units
TARS•Tarsus Pharmaceuticals granted Chief Commercial Officer Neera Clase 10,587 stock options and 6,678 restricted stock units on Nov. 3, 2026.
